Childress Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Childress Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$748K	Sell	12,974 -597	-4%	-$34.3K	0.12%	119
2026 Q1	$823K	Buy	13,571 +1,193	+10%	+$69.5K	0.15%	102
2025 Q4	$668K	Buy	12,378 +4,283	+53%	+$206K	0.11%	137
2025 Q3	$365K	Buy	8,095 +2,874	+55%	+$134K	0.07%	193
2025 Q2	$242K	Sell	5,221 -608	-10%	-$29.8K	0.06%	216
2025 Q1	$356K	Sell	5,829 -1,189	-17%	-$69.3K	0.1%	143
2024 Q4	$397K	Buy	7,018 +1,051	+18%	+$58.7K	0.11%	127
2024 Q3	$309K	Buy	+5,967	New	+$280K	0.08%	164
2024 Q2	–	Sell	-4,679	Closed	-$254K	–	224
2024 Q1	$254K	Buy	+4,679	New	+$238K	0.07%	173
2023 Q4	–	Sell	-4,804	Closed	-$265K	–	203
2023 Q3	$265K	Buy	+4,804	New	+$294K	0.09%	141
2023 Q1	–	Sell	-8,210	Closed	-$591K	–	100
2022 Q4	$591K	Buy	8,210 +365	+5%	+$27.5K	0.2%	75
2022 Q3	$567K	Sell	7,845 -886	-10%	-$64.3K	0.22%	76
2022 Q2	$672K	Buy	8,731 +367	+4%	+$28K	0.27%	67
2022 Q1	$612K	Buy	8,364 +1,833	+28%	+$123K	0.21%	84
2021 Q4	$407K	Sell	6,531 -1,351	-17%	-$79.3K	0.17%	106
2021 Q3	$465K	Buy	7,882 +1,461	+23%	+$96.2K	0.19%	98
2021 Q2	$429K	Sell	6,421 -1,574	-20%	-$103K	0.2%	89
2021 Q1	$504K	Buy	7,995 +3,234	+68%	+$201K	0.23%	86
2020 Q4	$297K	Buy	+4,761	New	+$293K	0.17%	71

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Childress Capital Advisors's BMY Position: Q2 2026 in Review

Childress Capital Advisors reduced its Bristol-Myers Squibb (BMY) stake by 4.4% in Q2 2026, selling an estimated $34.3K and leaving 12,974 shares worth $748K. The position accounts for 0.12% of the portfolio, ranked #119.

Childress Capital Advisors first reported a position in BMY in Q4 2020 and has held it in 19 quarters since. The position peaked at $823K in Q1 2026. 2,520 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Childress Capital Advisors held 12,974 shares of Bristol-Myers Squibb worth $748K as of Q2 2026.
Childress Capital Advisors sold 597 Bristol-Myers Squibb shares in Q2 2026, an estimated $34.3K.
Bristol-Myers Squibb made up 0.12% of Childress Capital Advisors's portfolio in Q2 2026, its #119 holding.
Childress Capital Advisors first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 19 quarters since.
Childress Capital Advisors's Bristol-Myers Squibb position peaked at $823K in Q1 2026.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Childress Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.